phosphoramidic acid has been researched along with Hemorrhagic Fever, Ebola in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bannister, R; Barauskas, O; Bavari, S; Carra, E; Chun, K; Cihlar, T; Clarke, MO; Doerffler, E; Feng, JY; Hui, HC; Jordan, R; Knox, J; Lee, G; Lee, WA; Lew, W; Lo, MK; Mackman, RL; Neville, S; Perron, M; Perry, J; Ray, AS; Rheingold, AL; Ross, B; Siegel, D; Soloveva, V; Stray, KM; Strickley, R; Swaminathan, S; Wang, Q; Warren, TK; Wolfe, L; Xu, Y; Zhang, L | 1 |
1 other study(ies) available for phosphoramidic acid and Hemorrhagic Fever, Ebola
Article | Year |
---|---|
Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses.
Topics: Adenosine Monophosphate; Alanine; Amides; Cell Line; Drug Discovery; Hemorrhagic Fever, Ebola; Humans; Microbial Sensitivity Tests; Phosphoric Acids; Prodrugs; Ribonucleotides; Structure-Activity Relationship; Virus Diseases | 2017 |